The Community Guide

- gsearch

Search Results

Narrow Results:

2023 1
2021 2
2020 3
2019 4
2018 1
2017 2
2015 3

The LondonCOVID Group 1

Journal Article 15
Letter 1

Letter 1

1 - 16 of 16 Results

Refine Results

Refine Results:

Impact of Maternal HIV Seroconversion during Pregnancy on Early Mother to Child Transmission of HIV (MTCT) Measured at 4-8 Weeks Postpartum in South Africa 2011-2012: A National Population-Based Evaluation

CITE Title : Impact of Maternal HIV Seroconversion during Pregnancy on Early Mother to Child Transmission of HIV (MTCT) Measured at 4-8 Weeks Postpartum in South Africa 2011-2012: A National Population-Based Evaluation Personal Author(s) : Dinh, Thu-Ha;Delaney, Kevin P.;Goga, Ameena;Jackson, Debra;Lombard, Carl;Woldesenbet, Selamawit;Mogashoa, Mary;Pillay, Yogan;Shaffer, Nathan; Published Date : May 05 2015 Series : PEPFAR Source : PLoS One. 10(5). URL : https://stacks.cdc.gov/view/cdc/43359 Dinh, Thu-Ha et al. (2015). Impact of Maternal HIV Seroconversion during Pregnancy on Early Mother to Child Transmission of HIV (MTCT) Measured at 4-8 Weeks Postpartum in South Africa 2011-2012: A National Population-Based Evaluation. 10(5). Dinh, Thu-Ha et al. "Impact of Maternal HIV Seroconversion during Pregnancy on Early Mother to Child Transmission of HIV (MTCT) Measured at 4-8 Weeks Postpartum in South Africa 2011-2012: A National Population-Based Evaluation" 10, no. 5 (2015) Dinh, Thu-Ha et al. "Impact of Maternal HIV Seroconversion during Pregnancy on Early Mother to Child Transmission of HIV (MTCT) Measured at 4-8 Weeks Postpartum in South Africa 2011-2012: A National Population-Based Evaluation" vol. 10, no. 5, 2015 Export RIS Citation Information.

:

Dinh, Thu-Ha ;

Delaney, Kevin P.

May 05 2015 | PEPFAR

:

BackgroundMother-to-child transmission of HIV (MTCT) depends on the timing of HIV infection. We estimated HIV-seroconversion during pregnancy (HSP) af...
Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK

CITE Title : Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK Personal Author(s) : Shrotri, Madhumita;Harris, Ross J.;Rodger, Alison;Planche, Timothy;Sanderson, Frances;Mahungu, Tabitha;McGregor, Alastair;Heath, Paul T.;Brown, Colin S.;Dunning, Jake;Hopkins, Susan;Ladhani, Shamez;Chand, Meera; Corporate Authors(s) : The LondonCOVID Group Published Date : March 18 2021 Source : Emerg Infect Dis. 27(4):1155-1158 URL : https://stacks.cdc.gov/view/cdc/104878 Shrotri, Madhumita et al. (2021). Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK. 27(4). Shrotri, Madhumita et al. "Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK" 27, no. 4 (2021) Shrotri, Madhumita et al. "Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK" vol. 27, no. 4, 2021 Export RIS Citation Information.

:

Shrotri, Madhumita ;

Harris, Ross J.

March 18 2021 | Emerg Infect Dis. 27(4):1155-1158

:

Prospective serosurveillance of severe acute respiratory syndrome coronavirus 2 in 1,069 healthcare workers in London, UK, demonstrated that nucleocap...
Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries

CITE Title : Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries Personal Author(s) : Baker, Julia M.;Tate, Jacqueline E.;Leon, Juan;Haber, Michael J.;Lopman, Benjamin A.; Published Date : December 30 2019 Source : PLoS Med. 16(12) URL : https://stacks.cdc.gov/view/cdc/90805 Baker, Julia M. et al. (2019). Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries. 16(12). Baker, Julia M. et al. "Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries" 16, no. 12 (2019) Baker, Julia M. et al. "Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries" vol. 16, no. 12, 2019 Export RIS Citation Information.

:

Baker, Julia M. ;

Tate, Jacqueline E.

December 30 2019 | PLoS Med. 16(12)

:

BackgroundDespite the success of rotavirus vaccines over the last decade, rotavirus remains a leading cause of severe diarrheal disease among young ch...
Multiplex serology for impact evaluation of bed net distribution on burden of lymphatic filariasis and four species of human malaria in northern Mozambique

CITE Title : Multiplex serology for impact evaluation of bed net distribution on burden of lymphatic filariasis and four species of human malaria in northern Mozambique Personal Author(s) : Plucinski, Mateusz M.;Candrinho, Baltazar;Chambe, Geraldo;Muchanga, João;Muguande, Olinda;Matsinhe, Graça;Mathe, Guidion;Rogier, Eric;Doyle, Timothy;Zulliger, Rose;Colborn, James;Saifodine, Abu;Lammie, Patrick;Priest, Jeffrey W.; Published Date : Feb 14 2018 Source : PLoS Negl Trop Dis. 12(2). URL : https://stacks.cdc.gov/view/cdc/53099 Plucinski, Mateusz M. et al. (2018). Multiplex serology for impact evaluation of bed net distribution on burden of lymphatic filariasis and four species of human malaria in northern Mozambique. 12(2). Plucinski, Mateusz M. et al. "Multiplex serology for impact evaluation of bed net distribution on burden of lymphatic filariasis and four species of human malaria in northern Mozambique" 12, no. 2 (2018) Plucinski, Mateusz M. et al. "Multiplex serology for impact evaluation of bed net distribution on burden of lymphatic filariasis and four species of human malaria in northern Mozambique" vol. 12, no. 2, 2018 Export RIS Citation Information.

:

Plucinski, Mateusz M. ;

Candrinho, Baltazar

Feb 14 2018 | PLoS Negl Trop Dis. 12(2).

:

BackgroundUniversal coverage with long-lasting insecticidal nets (LLINs) is a primary control strategy against Plasmodium falciparum malaria. However,...
IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection

CITE Title : IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection Personal Author(s) : Staines, Henry M.;Kirwan, Daniela E.;Clark, David J.;Adams, Emily R.;Augustin, Yolanda;Byrne, Rachel L.;Cocozza, Michael;Cubas-Atienzar, Ana I.;Cuevas, Luis E.;Cusinato, Martina;Davies, Benedict M.O.;Davis, Mark;Davis, Paul;Duvoix, Annelyse;Eckersley, Nicholas M.;Forton, Daniel;Fraser, Alice J.;Garrod, Gala;Hadcocks, Linda;Hu, Qinxue;Johnson, Michael;Kay, Grant A.;Klekotko, Kesja;Lewis, Zawditu;Macallan, Derek C.;Mensah-Kane, Josephine;Menzies, Stefanie;Monahan, Irene;Moore, Catherine M.;Nebe-von-Caron, Gerhard;Owen, Sophie I.;Sainter, Chris;Sall, Amadou A.;Schouten, James;Williams, Christopher T.;Wilkins, John;Woolston, Kevin;Fitchett, Joseph R.A.;Krishna, Sanjeev;Planche, Tim; Published Date : November 30 2020 Source : Emerg Infect Dis. 27(1):85-91 URL : https://stacks.cdc.gov/view/cdc/99987 Staines, Henry M. et al. (2020). IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection. 27(1). Staines, Henry M. et al. "IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection" 27, no. 1 (2020) Staines, Henry M. et al. "IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection" vol. 27, no. 1, 2020 Export RIS Citation Information.

:

Staines, Henry M. ;

Kirwan, Daniela E.

November 30 2020 | Emerg Infect Dis. 27(1):85-91

:

We investigated the dynamics of seroconversion in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. During March 29-May 22, 2020...
Predictors of Nonseroconversion after SARS-CoV-2 Infection

CITE Title : Predictors of Nonseroconversion after SARS-CoV-2 Infection Personal Author(s) : Liu, Weimin;Russell, Ronnie M.;Bibollet-Ruche, Frederic;Skelly, Ashwin N.;Sherrill-Mix, Scott;Freeman, Drew A.;Stoltz, Regina;Lindemuth, Emily;Lee, Fang-Hua;Sterrett, Sarah;Bar, Katharine J.;Erdmann, Nathaniel;Gouma, Sigrid;Hensley, Scott E.;Ketas, Thomas;Cupo, Albert;Cruz Portillo, Victor M.;Moore, John P.;Bieniasz, Paul D.;Hatziioannou, Theodora;Massey, Greer;Minyard, Mary-Beth;Saag, Michael S.;Davis, Randall S.;Shaw, George M.;Britt, William J.;Leal, Sixto M.;Goepfert, Paul;Hahn, Beatrice H.; Published Date : September 2021 Source : Emerg Infect Dis. 27(9):2454-2458 URL : https://stacks.cdc.gov/view/cdc/109722 Liu, Weimin et al. (2021). Predictors of Nonseroconversion after SARS-CoV-2 Infection. 27(9). Liu, Weimin et al. "Predictors of Nonseroconversion after SARS-CoV-2 Infection" 27, no. 9 (2021) Liu, Weimin et al. "Predictors of Nonseroconversion after SARS-CoV-2 Infection" vol. 27, no. 9, 2021 Export RIS Citation Information.

:

Liu, Weimin ;

Russell, Ronnie M.

September 2021 | Emerg Infect Dis. 27(9):2454-2458

:

Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show...
$Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine A novel dose sparing immunization schedule$

Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule

CITE Title : Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule Personal Author(s) : Anand, Abhijeet;Molodecky, Natalie A.;Pallansch, Mark A.;Sutter, Roland W.; Published Date : 5 19 2017;5-19-; Source : Vaccine. 35(22):2993-2998 URL : https://stacks.cdc.gov/view/cdc/132023 Anand, Abhijeet et al. (2017). Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule. 35(22). Anand, Abhijeet et al. "Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule" 35, no. 22 (2017) Anand, Abhijeet et al. "Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule" vol. 35, no. 22, 2017 Export RIS Citation Information.

:

Anand, Abhijeet ;

Molodecky, Natalie A.

5 19 2017 | Vaccine. 35(22):2993-2998

:

Introduction:The polio eradication endgame strategic plan calls for the sequential removal of Sabin poliovirus serotypes from the trivalent oral polio...
Outbreak — Final Report

CITE Title : Outbreak — Final Report Personal Author(s) : Casey, Rebecca M.;Harris, Jennifer B.;Ahuka-Mundeke, Steve;Dixon, Meredith G.;Kizito, Gabriel M.;Nsele, Pierre M.;Umutesi, Grace;Laven, Janeen;Kosoy, Olga;Paluku, Gilson;Gueye, Abdou S.;Hyde, Terri B.;Ewetola, Raimi;Sheria, Guylain K.M.;Muyembe-Tamfum, Jean-Jacques;Staples, J. Erin; Published Date : 8 01 2019 Source : N Engl J Med. 381(5):444-454 URL : https://stacks.cdc.gov/view/cdc/85845 Casey, Rebecca M. et al. (2019). Outbreak — Final Report. 381(5). Casey, Rebecca M. et al. "Outbreak — Final Report" 381, no. 5 (2019) Casey, Rebecca M. et al. "Outbreak — Final Report" vol. 381, no. 5, 2019 Export RIS Citation Information.

:

Casey, Rebecca M. ;

Harris, Jennifer B.

8 01 2019 | N Engl J Med. 381(5):444-454

:

BACKGROUNDIn 2016, the response to a yellow fever outbreak in Angola and the Democratic Republic of Congo led to a global shortage of yellow fever vac...
Mild and asymptomatic influenza B virus infection among unvaccinated pregnant persons: Implication for effectiveness of non-pharmaceutical intervention and vaccination to prevent influenza

CITE Title : Mild and asymptomatic influenza B virus infection among unvaccinated pregnant persons: Implication for effectiveness of non-pharmaceutical intervention and vaccination to prevent influenza Personal Author(s) : Chen, Liling;Levine, Min Z.;Zhou, Suizan;Bai, Tian;Pang, Yuanyuan;Bao, Lin;Tan, Yayun;Cui, Pengwei;Zhang, Ran;Millman, Alexander J.;Greene, Carolyn M.;Zhang, Zhongwei;Wang, Yan;Zhang, Jun; Published Date : 1 16 2023;1-16-; Source : Vaccine. 41(3):694-701 URL : https://stacks.cdc.gov/view/cdc/129652 Chen, Liling et al. (2023). Mild and asymptomatic influenza B virus infection among unvaccinated pregnant persons: Implication for effectiveness of non-pharmaceutical intervention and vaccination to prevent influenza. 41(3). Chen, Liling et al. "Mild and asymptomatic influenza B virus infection among unvaccinated pregnant persons: Implication for effectiveness of non-pharmaceutical intervention and vaccination to prevent influenza" 41, no. 3 (2023) Chen, Liling et al. "Mild and asymptomatic influenza B virus infection among unvaccinated pregnant persons: Implication for effectiveness of non-pharmaceutical intervention and vaccination to prevent influenza" vol. 41, no. 3, 2023 Export RIS Citation Information.

:

Chen, Liling ;

Levine, Min Z.

1 16 2023 | Vaccine. 41(3):694-701

:

Background:We estimated symptomatic and asymptomatic influenza infection frequency in community-dwelling unvaccinated pregnant persons to inform risk ...
Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France

CITE Title : Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France Personal Author(s) : Gallais, Floriane;Velay, Aurélie;Nazon, Charlotte;Wendling, Marie-Josée;Partisani, Marialuisa;Sibilia, Jean;Candon, Sophie;Fafi-Kremer, Samira; Published Date : December 01 2020 Source : Emerg Infect Dis. 27(1):113-121 URL : https://stacks.cdc.gov/view/cdc/100003 Gallais, Floriane et al. (2020). Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France. 27(1). Gallais, Floriane et al. "Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France" 27, no. 1 (2020) Gallais, Floriane et al. "Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France" vol. 27, no. 1, 2020 Export RIS Citation Information.

:

Gallais, Floriane ;

Velay, Aurélie

December 01 2020 | Emerg Infect Dis. 27(1):113-121

:

We investigated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies and T-cell responses against SARS-CoV-2 and human cor...
Seroconversions to Rickettsiae in US Military Personnel in South Korea

CITE Title : Seroconversions to Rickettsiae in US Military Personnel in South Korea Personal Author(s) : Jiang, Ju;Myers, Todd E.;Rozmajzl, Patrick J.;Graf, Paul C.F.;Chretien, Jean-Paul;Gaydos, Joel C.;Richards, Allen L.; Published Date : Jun 2015 Source : Emerg Infect Dis. 21(6):1073-1074. URL : https://stacks.cdc.gov/view/cdc/31454 Jiang, Ju et al. (2015). Seroconversions to Rickettsiae in US Military Personnel in South Korea. 21(6). Jiang, Ju et al. "Seroconversions to Rickettsiae in US Military Personnel in South Korea" 21, no. 6 (2015) Jiang, Ju et al. "Seroconversions to Rickettsiae in US Military Personnel in South Korea" vol. 21, no. 6, 2015 Export RIS Citation Information.

:

Jiang, Ju ;

Myers, Todd E.

Jun 2015 | Emerg Infect Dis. 21(6):1073-1074.

No Description
High Coxiella burnetii Seroconversion Rate in Veterinary Students, the Netherlands, 2006–2010

CITE Title : High Coxiella burnetii Seroconversion Rate in Veterinary Students, the Netherlands, 2006–2010 Personal Author(s) : de Lange, Marit M.A.;van der Hoek, Wim;Schneeberger, Peter M.;Swart, Arno;Heederik, Dick J.J.;Schimmer, Barbara;Wouters, Inge M.; Published Date : Dec 2020 Source : Emerg Infect Dis. 26(12):3086-3088 URL : https://stacks.cdc.gov/view/cdc/98413 de Lange, Marit M.A. et al. (2020). High Coxiella burnetii Seroconversion Rate in Veterinary Students, the Netherlands, 2006–2010. 26(12). de Lange, Marit M.A. et al. "High Coxiella burnetii Seroconversion Rate in Veterinary Students, the Netherlands, 2006–2010" 26, no. 12 (2020) de Lange, Marit M.A. et al. "High Coxiella burnetii Seroconversion Rate in Veterinary Students, the Netherlands, 2006–2010" vol. 26, no. 12, 2020 Export RIS Citation Information.

:

de Lange, Marit M.A. ;

van der Hoek, Wim

Dec 2020 | Emerg Infect Dis. 26(12):3086-3088

:

We examined Coxiella burnetii seroconversion rates by measuring C. burnetii IgG among 2 cohorts of veterinary students. During follow-up of 118 serone...
A Multiplex HIV Incidence Assay for Inferring Recent HIV-1 Transmission and Time of Infection

CITE Title : A Multiplex HIV Incidence Assay for Inferring Recent HIV-1 Transmission and Time of Infection Personal Author(s) : Curtis, Kelly A.;Campbell, Ellsworth M.;Hanson, Debra L.;Rudolph, Donna L.;Duwve, Joan;Blosser, Sara;Gentry, Jessica;Lovchik, Judy;Peters, Philip J.;Owen, S. Michele;Switzer, William M.; Published Date : 4 01 2019;4-01-; Source : J Acquir Immune Defic Syndr. 80(4):454-460 URL : https://stacks.cdc.gov/view/cdc/160366 Curtis, Kelly A. et al. (2019). A Multiplex HIV Incidence Assay for Inferring Recent HIV-1 Transmission and Time of Infection. 80(4). Curtis, Kelly A. et al. "A Multiplex HIV Incidence Assay for Inferring Recent HIV-1 Transmission and Time of Infection" 80, no. 4 (2019) Curtis, Kelly A. et al. "A Multiplex HIV Incidence Assay for Inferring Recent HIV-1 Transmission and Time of Infection" vol. 80, no. 4, 2019 Export RIS Citation Information.

:

Curtis, Kelly A. ;

Campbell, Ellsworth M.

4 01 2019 | J Acquir Immune Defic Syndr. 80(4):454-460

:

Background:Laboratory assays for determining recent HIV-1 infection are an important public health tool for aiding in the estimation of HIV incidence....
Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14–14–2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial

CITE Title : Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14–14–2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial Personal Author(s) : Li, Yan;Chu, Susan Y;Yue, Chenyan;Wannemuehler, Kathleen;Xie, Shuyun;Zhang, Fubin;Wang, Yamin;Zhang, Yuxi;Ma, Rui;Li, Yumin;Zuo, Zhiping;Rodewald, Lance;Xiao, Qiyou;Feng, Zijian;Wang, Huaqing;An, Zhijie; Published Date : 4 2019;4-2019; Source : Lancet Infect Dis. 19(4):402-409 URL : https://stacks.cdc.gov/view/cdc/174561 Li, Yan et al. (2019). Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14–14–2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial. 19(4). Li, Yan et al. "Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14–14–2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial" 19, no. 4 (2019) Li, Yan et al. "Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14–14–2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial" vol. 19, no. 4, 2019 Export RIS Citation Information.

:

Li, Yan ;

Chu, Susan Y

4 2019 | Lancet Infect Dis. 19(4):402-409

:

BackgroundIn China, measles-rubella vaccine and live attenuated SA 14–14–2 Japanese encephalitis vaccine (LJEV) are recommended for simultaneous a...
Arsenic exposure and hepatitis E virus infection during pregnancy

CITE Title : Arsenic exposure and hepatitis E virus infection during pregnancy Personal Author(s) : Heaney, Christopher D.;Kmush, Brittany;Navas-Acien, Ana;Francesconi, Kevin;Gössler, Walter;Schulze, Kerry;Fairweather, DeLisa;Mehra, Sucheta;Nelson, Kenrad E.;Klein, Sabra L.;Li, Wei;Ali, Hasmot;Shaikh, Saijuddin;Merrill, Rebecca D.;Wu, Lee;West, Keith P.;Christian, Parul;Labrique, Alain B.; Published Date : 10 2015;10-2015; Source : Environ Res. 142:273-280 URL : https://stacks.cdc.gov/view/cdc/35079 Heaney, Christopher D. et al. (2015). Arsenic exposure and hepatitis E virus infection during pregnancy. 142 Heaney, Christopher D. et al. "Arsenic exposure and hepatitis E virus infection during pregnancy" 142 (2015) Heaney, Christopher D. et al. "Arsenic exposure and hepatitis E virus infection during pregnancy" vol. 142, 2015 Export RIS Citation Information.

:

Heaney, Christopher D. ;

Kmush, Brittany

10 2015 | Environ Res. 142:273-280

:

BackgroundArsenic has immunomodulatory properties and may have the potential to alter susceptibility to infection in humans.ObjectivesWe aimed to asse...
Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America

CITE Title : Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America Personal Author(s) : Lopez-Medina, Eduardo;Melgar, Mario;Gaensbauer, James T.;Bandyopadhyay, Ananda S.;Borate, Bhavesh R.;Weldon, William C.;Rüttimann, Ricardo;Ward, Joel;Clemens, Ralf;Asturias, Edwin J.; Published Date : Apr 25 2017 Source : Vaccine. 2017; 35(28):3591-3597. URL : https://stacks.cdc.gov/view/cdc/46279 Lopez-Medina, Eduardo et al. (2017). Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America. 35(28). Lopez-Medina, Eduardo et al. "Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America" 35, no. 28 (2017) Lopez-Medina, Eduardo et al. "Inactivated polio vaccines from three different manufacturers have equivalent safety and immunogenicity when given as 1 or 2 additional doses after bivalent OPV: Results from a randomized controlled trial in Latin America" vol. 35, no. 28, 2017 Export RIS Citation Information.

:

Lopez-Medina, Eduardo ;

Melgar, Mario

Apr 25 2017 | Vaccine. 2017; 35(28):3591-3597.

:

BackgroundSince April 2016 inactivated poliovirus vaccine (IPV) has been the only routine source of polio type 2 protection worldwide. With IPV supply...